Intraperitoneal Chemotherapy in Advanced Ovarian Cancer: Old and Novel Questions

被引：3
作者：
Tomao, Federica [1 ]
Panici, Pierluigi Benedetti [1 ]
Tomao, Silverio [1 ]
机构：
[1] Univ Roma Sapienza, Rome, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 33期
关键词：
EPITHELIAL OVARIAN; FALLOPIAN-TUBE; BEVACIZUMAB; PACLITAXEL; CARBOPLATIN; CARCINOMA; TRIAL;
D O I：
10.1200/JCO.19.01163
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3168 / +
页数：3
相关论文
共 10 条
[1]   Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer [J].
Burger, Robert A. ;
Brady, Mark F. ;
Bookman, Michael A. ;
Fleming, Gini F. ;
Monk, Bradley J. ;
Huang, Helen ;
Mannel, Robert S. ;
Homesley, Howard D. ;
Fowler, Jeffrey ;
Greer, Benjamin E. ;
Boente, Matthew ;
Birrer, Michael J. ;
Liang, Sharon X. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (26) :2473-2483
[2]   Intraperitoneal chemotherapy comes of age [J].
Cannistra, SA .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (01) :77-79
[3]   Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer [J].
Chan, J. K. ;
Brady, M. F. ;
Penson, R. T. ;
Huang, H. ;
Birrer, M. J. ;
Walker, J. L. ;
DiSilvestro, P. A. ;
Rubin, S. C. ;
Martin, L. P. ;
Davidson, S. A. ;
Huh, W. K. ;
O'Malley, D. M. ;
Boente, M. P. ;
Michael, H. ;
Monk, B. J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (08) :738-748
[4]   Phase I feasibility study of intraperitoneal cisplatin and intravenous paclitaxel followed by intraperitoneal paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A gynecologic oncology group study [J].
Dizon, Don S. ;
Sill, Michael W. ;
Gould, Natalie ;
Rubin, Stephen C. ;
Yamada, S. Diane ;
DeBernardo, Robert L. ;
Mannel, Robert S. ;
Eisenhauer, Eric L. ;
Duska, Linda R. ;
Fracasso, Paula M. .
GYNECOLOGIC ONCOLOGY, 2011, 123 (02) :182-186
[5]   Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial [J].
Katsumata, Noriyuki ;
Yasuda, Makoto ;
Isonishi, Seiji ;
Takahashi, Fumiaki ;
Michimae, Hirofumi ;
Kimura, Eizo ;
Aoki, Daisuke ;
Jobo, Toshiko ;
Kodama, Shoji ;
Terauchi, Fumitoshi ;
Sugiyama, Toru ;
Ochiai, Kazunori .
LANCET ONCOLOGY, 2013, 14 (10) :1020-1026
[6]   Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: A Gynecologic Oncology Group study [J].
Landrum, Lisa M. ;
Java, James ;
Mathews, Cara A. ;
Lanneau, Grainger S., Jr. ;
Copeland, Larry J. ;
Armstrong, Deborah K. ;
Walker, Joan L. .
GYNECOLOGIC ONCOLOGY, 2013, 130 (01) :12-18
[7]   Phase II trial of weekly paclitaxel (80 mg/m2) in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers:: A Gynecologic Oncology Group study [J].
Markman, Maurie ;
Blessing, John ;
Rubin, Stephen C. ;
Connor, Joseph ;
Hanjani, Parviz ;
Waggoner, Steven .
GYNECOLOGIC ONCOLOGY, 2006, 101 (03) :436-440
[8]   Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial [J].
Oza, Amit M. ;
Cook, Adrian D. ;
Pfisterer, Jacobus ;
Embleton, Andrew ;
Ledermann, Jonathan A. ;
Pujade-Lauraine, Eric ;
Kristensen, Gunnar ;
Carey, Mark S. ;
Beale, Philip ;
Cervantes, Andres ;
Park-Simon, Tjoung-Won ;
Rustin, Gordon ;
Joly, Florence ;
Mirza, Mansoor R. ;
Plante, Marie ;
Quinn, Michael ;
Poveda, Andres ;
Jayson, Gordon C. ;
Stark, Dan ;
Swart, Ann Marie ;
Farrelly, Laura ;
Kaplan, Richard ;
Parmar, Mahesh K. B. ;
Perren, Timothy J. .
LANCET ONCOLOGY, 2015, 16 (08) :928-936
[9]   Bevacizumab in ovarian cancer: A critical review of phase III studies [J].
Rossi, Luigi ;
Verrico, Monica ;
Zaccarelli, Eleonora ;
Papa, Anselmo ;
Colonna, Maria ;
Strudel, Martina ;
Vici, Patrizia ;
Bianco, Vincenzo ;
Tomao, Federica .
ONCOTARGET, 2017, 8 (07) :12389-12405
[10]   Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study [J].
Walker, Joan L. ;
Brady, Mark F. ;
Wenzel, Lari ;
Fleming, Gini F. ;
Huang, Helen Q. ;
DiSilvestro, Paul A. ;
Fujiwara, Keiichi ;
Alberts, David S. ;
Zheng, Wenxin ;
Tewari, Krishnansu S. ;
Cohn, David E. ;
Powell, Matthew A. ;
Van Le, Linda ;
Davidson, Susan A. ;
Gray, Heidi J. ;
Rose, Peter G. ;
Aghajanian, Carol ;
Myers, Tashanna ;
Secord, Angeles Alvarez ;
Rubin, Stephen C. ;
Mannel, Robert S. .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (16) :1380-+
1